Contemporary use of prasugrel in clinical practice: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.

@article{Sandhu2013ContemporaryUO,
  title={Contemporary use of prasugrel in clinical practice: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.},
  author={Amneet Sandhu and Milan C Seth and Simon R. Dixon and David A Share and David H W Wohns and Thomas A Lalonde and Mauro Moscucci and Arthur L. Riba and Michael Grossman and Hitinder S. Gurm},
  journal={Circulation. Cardiovascular quality and outcomes},
  year={2013},
  volume={6 3},
  pages={293-8}
}
BACKGROUND Prasugrel is a recently approved thienopyridine for use in patients with acute coronary syndromes undergoing percutaneous coronary intervention. There are no data on contemporary use of prasugrel in routine clinical practice. METHODS AND RESULTS We assessed the patterns of prasugrel use among 55 821 patients who underwent percutaneous coronary intervention and were discharged alive from January 2010 to December 2011 at 44 hospitals participating in the Blue Cross Blue Shield of… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS
13 Citations
9 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

References

Publications referenced by this paper.
Showing 1-9 of 9 references

Similar Papers

Loading similar papers…